Literature DB >> 21442030

Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines.

Aziz Alami Chentoufi1, Lbachir BenMohamed.   

Abstract

Entities:  

Year:  2010        PMID： 21442030      PMCID： PMC3063648          DOI： 10.2217/fvl.10.44

Source DB:  PubMed          Journal:  Future Virol        ISSN： 1746-0794            Impact factor:   1.831


× No keyword cloud information.
  17 in total

Review 1.  Delivery using herpes simplex virus: an overview.

Authors:  William F Goins; Darren Wolfe; David M Krisky; Qing Bai; Ed A Burton; David J Fink; Joseph C Glorioso
Journal:  Methods Mol Biol       Date:  2004

2.  Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.

Authors:  Amitinder Kaur; Hannah B Sanford; Deirdre Garry; Sabine Lang; Sherry A Klumpp; Daisuke Watanabe; Roderick T Bronson; Jeffrey D Lifson; Margherita Rosati; George N Pavlakis; Barbara K Felber; David M Knipe; Ronald C Desrosiers
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

Review 3.  HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy.

Authors:  Alberto L Epstein; Peggy Marconi; Rafaela Argnani; Roberto Manservigi
Journal:  Curr Gene Ther       Date:  2005-10       Impact factor: 4.391

4.  In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.

Authors:  Corinna La Rosa; Zhongde Wang; Simon F Lacey; Maria M Lalimarmo; Aparna Krishnan; Jeff Longmate; Don J Diamond
Journal:  Exp Hematol       Date:  2006-04       Impact factor: 3.084

5.  Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.

Authors:  G L Smith; M Mackett; B Moss
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

6.  Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates.

Authors:  Jacqueline N Parker; Luz-Andrea Pfister; Debra Quenelle; G Yancey Gillespie; James M Markert; Earl R Kern; Richard J Whitley
Journal:  Vaccine       Date:  2005-10-05       Impact factor: 3.641

7.  HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  R Furlan; A Bergami; E Brambilla; E Butti; M G De Simoni; M Campagnoli; P Marconi; G Comi; G Martino
Journal:  Gene Ther       Date:  2006-08-24       Impact factor: 5.250

8.  Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivo.

Authors:  M Puntel; R J Barrett; S Mondkar; V Saxena; K M Kroeger; A K M Muhammad; C Liu; N Bondale; S Sciascia; W Xiong; Y Shi; A Salem; A Zadmehr; P Huynh; D Palmer; P Ng; M G Castro; P R Lowenstein
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Authors:  S Harrow; V Papanastassiou; J Harland; R Mabbs; R Petty; M Fraser; D Hadley; J Patterson; S M Brown; R Rampling
Journal:  Gene Ther       Date:  2004-11       Impact factor: 5.250

Review 10.  Herpes vector-mediated gene transfer in the treatment of chronic pain.

Authors:  Joseph C Glorioso; David J Fink
Journal:  Mol Ther       Date:  2008-10-07       Impact factor: 11.454
View more
  19 in total

1.  Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Elizabeth Kritzer; Sravya Chilukuri; Sumit Garg; David C Yu; Hawa Vahed; Lei Huang; Sabrina A Syed; Julie N Furness; Tien T Tran; Nesburn B Anthony; Christine E McLaren; John Sidney; Alessandro Sette; Randolph J Noelle; Lbachir BenMohamed
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

2.  Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine.

Authors:  Xavier Dervillez; Chetan Gottimukkala; Khaled W Kabbara; Chelsea Nguyen; Tina Badakhshan; Sarah M Kim; Anthony B Nesburn; Steven L Wechsler; Lbachir Benmohamed
Journal:  Future Virol       Date:  2012-04-01       Impact factor: 1.831

3.  The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism.

Authors:  Aziz A Chentoufi; Elizabeth Kritzer; Michael V Tran; Gargi Dasgupta; Chang Hyun Lim; David C Yu; Rasha E Afifi; Xianzhi Jiang; Dale Carpenter; Nelson Osorio; Chinhui Hsiang; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

4.  Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.

Authors:  Xiuli Zhang; Xavier Dervillez; Aziz Alami Chentoufi; Tina Badakhshan; Ilham Bettahi; Lbachir Benmohamed
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

5.  A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.

Authors:  Ruchi Srivastava; Arif A Khan; Jiawei Huang; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

6.  The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells.

Authors:  Aziz Alami Chentoufi; Xavier Dervillez; Gargi Dasgupta; Chelsea Nguyen; Khaled W Kabbara; Xianzhi Jiang; Anthony B Nesburn; Steven L Wechsler; Lbachir Benmohamed
Journal:  Viral Immunol       Date:  2012-04-18       Impact factor: 2.257

7.  Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8+ TEM Cells Are Associated with Asymptomatic Herpes in Humans.

Authors:  Hawa Vahed; Anshu Agrawal; Ruchi Srivastava; Swayam Prakash; Pierre-Gregoire A Coulon; Soumyabrata Roy; Lbachir BenMohamed
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

8.  Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

Authors:  Aziz Alami Chentoufi; Xavier Dervillez; Pierre-Alain Rubbo; Tiffany Kuo; Xiuli Zhang; Nicolas Nagot; Edouard Tuaillon; Philippe Van De Perre; Anthony B Nesburn; Lbachir Benmohamed
Journal:  Curr Trends Immunol       Date:  2012

9.  Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.

Authors:  Xavier Dervillez; Huma Qureshi; Aziz A Chentoufi; Arif A Khan; Elizabeth Kritzer; David C Yu; Oscar R Diaz; Chetan Gottimukkala; Mina Kalantari; Maria C Villacres; Vanessa M Scarfone; Denise M McKinney; John Sidney; Alessandro Sette; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Immunol       Date:  2013-10-07       Impact factor: 5.422

10.  Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107+ CD8+ T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect against Ocular Herpes Challenge.

Authors:  Arif A Khan; Ruchi Srivastava; Hawa Vahed; Soumyabrata Roy; Sager S Walia; Grace J Kim; Mona A Fouladi; Taikun Yamada; Vincent T Ly; Cynthia Lam; Anthony Lou; Vivianna Nguyen; Undariya Boldbaatar; Roger Geertsema; Nigel W Fraser; Lbachir BenMohamed
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.